Relief Therapeutics Holding Stock Analysis

Relief OTC Stock Analysis Notes

About 22.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Relief Therapeutics recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. Mondobiotech Holding is traded on OTC Exchange in the United States.The quote for Relief Therapeutics Holding is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Relief Therapeutics Holding contact the company at 41 44 723 59 59 or learn more at https://www.relieftherapeutics.com.

Relief Therapeutics Investment Alerts

Relief Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 120.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Relief Therapeutics's market, we take the total number of its shares issued and multiply it by Relief Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 25th of February, Relief Therapeutics holds the Coefficient Of Variation of (728.56), variance of 20.25, and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Relief Therapeutics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Relief Therapeutics, which can be compared to its competitors. Please check Relief Therapeutics information ratio and potential upside to decide if Relief Therapeutics is priced some-what accurately, providing market reflects its current price of 3.45 per share. Given that Relief Therapeutics has information ratio of (0.14), we recommend you to check out Relief Therapeutics's recent market performance to make sure the company can sustain itself at a future point.

Relief Therapeutics Price Movement Analysis

Relief Therapeutics Outstanding Bonds

Relief Therapeutics Predictive Daily Indicators

Relief Therapeutics Forecast Models

Relief Therapeutics' time-series forecasting models are one of many Relief Therapeutics' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Relief Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Relief Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Relief shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Relief Therapeutics. By using and applying Relief OTC Stock analysis, traders can create a robust methodology for identifying Relief entry and exit points for their positions.

When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.